Nicholas H. Chakiryan

Also affiliated with Portland VA Medical Center, Advisory Board Company (United States), OHSU Knight Cancer Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma”.

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma

Cancer Discovery(2022)10.1158/2159-8290.cd-21-0925

N/A

0DataRank · unranked

33 citations

Lynda Vuong, Josef Leibold, Nicholas H. Chakiryan, Michael Curry, Fengshen Kuo +31 more

Cabozantinib-Exposed Renal Cell Carcinoma Organoids Suggest Transcriptomic Associations with Treatment Resistance in Clear Cell and Nonclear Cell Tumors

Journal of Kidney Cancer and VHL(2025)10.15586/jkcvhl.v12i2.386

N/A

0DataRank · unranked

1 citations

Nicholas H. Chakiryan, George Thomas, Wesley H. Chou

Genomic and molecular associations with preoperative immune checkpoint inhibition in patients with stage III clear cell renal cell carcinoma

medRxiv(2025)10.1101/2025.07.31.25332518

N/A

0DataRank · unranked

0 citations

Lucy Lawrence, Emma Neham, Shreeram Akilesh, Amy E. Moran, Christopher L. Corless +10 more